Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem c...
Q1 2026
May 13, 2026
FY 2025
Mar 17, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 13, 2025